Jay Shepard
Director at Esperion Therapeutics, Inc. (ESPR)
Jay Shepard has filed 21 insider reports with the SEC since May 2021, as director at Esperion Therapeutics, Inc. (ESPR), director at Ironwood Pharmaceuticals Inc (IRWD) and director at Inovio Pharmaceuticals, Inc. (INO). The latest filing, on July 13, 2026, reports sale back to the company at Esperion Therapeutics, Inc. (ESPR).
- Filings
- 21
- Companies
- 3
- Bought on market
- None
- Sold on market
- None
Companies where Jay Shepard is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 0 | Jul 13, 2026 | |||||
| Director | 235,036 | $4.87 | Jun 17, 2026 | ||||
| Director | 9,209 | $1.63 | May 21, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jul 13, 2026ESPRDirector Shepard Jay returned 164,472 shares to the company, closing all direct ownership in the company to satisfy tax liabilityForm 4Sale back to the company
- Jun 16, 2026IRWDDirector Shepard Jay was granted 63,481 shares, increasing direct ownership by 37% to 235,036 unitsForm 4Grant or award
- May 28, 2026ESPRDirector Shepard Jay was granted 79,873 shares, increasing direct ownership by 94% to 164,472 unitsForm 4Grant or award
- May 20, 2026INOSEC Form 4 filed by Director Shepard JayForm 4Grant or award
- Jun 10, 2025IRWDDirector Shepard Jay was granted 45,000 shares, increasing direct ownership by 36% to 171,555 unitsForm 4Grant or award
- May 29, 2025ESPRDirector Shepard Jay was granted 33,000 shares, increasing direct ownership by 64% to 84,599 unitsForm 4Grant or award
- May 21, 2025INODirector Shepard Jay converted options into 2,167 shares, increasing direct ownership by 31% to 9,209 unitsForm 4Exercise or conversion of a derivative
- Jun 18, 2024IRWDDirector Shepard Jay was granted 24,311 shares, increasing direct ownership by 24% to 126,555 unitsForm 4Grant or award
- May 23, 2024ESPRShepard Jay was granted 23,000 shares, increasing direct ownership by 80% to 51,599 unitsForm 4Grant or award
- May 21, 2024INOSEC Form 4 filed by Shepard JayForm 4Grant or award
- May 15, 2024INOShepard Jay converted options into 2,166 shares, increasing direct ownership by 44% to 7,042 unitsForm 4Exercise or conversion of a derivative
- Jun 20, 2023IRWDSEC Form 4 filed by Shepard JayForm 4Grant or award
- Jun 15, 2023ESPRSEC Form 4 filed by Shepard JayForm 4Grant or award
- May 16, 2023INOSEC Form 4 filed by Shepard JayForm 4Grant or awardExercise or conversion of a derivative
- Jan 15, 2023INOSEC Form 4: Shepard Jay converted options into 4,273 shares, increasing direct ownership by 12% to 39,521 unitsForm 4Exercise or conversion of a derivative
- Jun 1, 2022IRWDSEC Form 4: Shepard Jay was granted 21,571 shares, increasing direct ownership by 37% to 79,894 unitsForm 4Grant or award
- May 26, 2022ESPRSEC Form 4 filed by Shepard JayForm 4Grant or award
- May 16, 2022INOSEC Form 4: Shepard Jay converted options into 18,000 shares, increasing direct ownership by 104% to 35,248 unitsForm 4Grant or awardExercise or conversion of a derivative
- Jan 15, 2022INOSEC Form 4: Shepard Jay converted options into 4,274 shares, increasing direct ownership by 33% to 17,248 unitsForm 4Exercise or conversion of a derivative
- Jun 2, 2021IRWDSEC Form 4: Shepard Jay was granted 22,766 units of Class A Common Stock, increasing direct ownership by 64% to 58,323 unitsForm 4Grant or award
- May 27, 2021ESPRSEC Form 4: Shepard Jay was granted 12,376 units of Common Stock, increasing direct ownership by 112% to 23,449 unitsForm 4Grant or award
Compare Jay Shepard with
- Jay Shepard vs Alexander J Denner1 shared
- Jay Shepard vs Jeffrey Silber1 shared
- Jay Shepard vs Robert E. Hoffman1 shared
- Jay Shepard vs J Martin Carroll1 shared
- Jay Shepard vs Fischer Seth H. Z.1 shared
- Jay Shepard vs John Craig Thompson1 shared
Other insiders at the same companies
- Alexander J DennerIRWD
- Jeffrey SilberIRWD
- Robert E. HoffmanESPR
- J Martin CarrollESPR
- Fischer Seth H. Z.ESPR
- John Craig ThompsonESPR
- John B. Harlow Jr.ESPR
- Benjamin LookerESPR
- Benjamin HalladayESPR
- Sheldon L. KoenigESPR
- Ronald SilverIRWD
- Marla L KesslerIRWD
- Mark G CurrieIRWD
- Jon R DuaneIRWD
- Julie McHughIRWD
- Catherine MoukheibirIRWD
Questions about Jay Shepard
- What is Jay Shepard's role at Esperion Therapeutics, Inc.?
- Jay Shepard reports to the SEC as director at Esperion Therapeutics, Inc. (ESPR), according to the latest filing on July 13, 2026. Jay Shepard has also filed as director at Ironwood Pharmaceuticals Inc (IRWD) and director at Inovio Pharmaceuticals, Inc. (INO).
- How many shares does Jay Shepard own?
- After the latest filing that states it, Jay Shepard directly owned 235,036 shares of Ironwood Pharmaceuticals Inc (IRWD) and 9,209 shares of Inovio Pharmaceuticals, Inc. (INO). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Jay Shepard bought or sold stock recently?
- No open-market purchases or sales by Jay Shepard are on file. The filings report sale back to the company, grant or award and exercise or conversion of a derivative.
- How do I get alerts when Jay Shepard files?
- Follow Jay Shepard on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Jay Shepard (SEC CIK 0001587788). Totals count each trade once, skipping amendments whose original is on file, from May 28, 2021 on. View on SEC EDGAR